An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a ...
BlackRock GIP, Adnoc, Temasek and L’IMAD launch a GCC & Central Asia infrastructure fund targeting energy, logistics, digital ...
Emirates News Agency on MSN
Global Infrastructure Partners, L’IMAD, ADNOC, Temasek to launch infrastructure partnership targeting $30 billion of investments
ABU DHABI, 14th May, 2026 (WAM) -- Global Infrastructure Partners (GIP), a part of BlackRock, will partner with L’IMAD, the Abu Dhabi National Oil Company (ADNOC) and Temasek to launch an ...
BlackRock's GIP has partnered with Singapore's Temasek and Abu Dhabi's newest wealth fund L’IMAD and state oil firm ADNOC to ...
DUBAI, May 14 (Reuters) - BlackRock's GIP has partnered with Singapore's Temasek and Abu Dhabi's newest wealth fund ...
RA tirzepatide for type 2 diabetes mellitus (T2DM) therapy has lower odds of instigating retinal complications.
BlackRock’s GIP partners with Temasek, L’IMAD, and ADNOC to target $30B in infrastructure deals across the Gulf. The alliance will raise equity and debt capital for greenfield and brownfield assets ...
Patients with obesity who were treated with GLP-1 receptor agonists or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists had a lower overall cancer risk and a lower risk ...
The firm, the only independent Australian firm with an office in London, advises on Australian law in the U.K. time zone.
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following ...
Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...
A Nature study reports a single-molecule GLP-1–GIP–lanifibranor quintuple agonist that targets incretin receptor-expressing cells while activating PPARα/γ/δ pathways. In obese and insulin-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results